Create an Rx‑format prescription for an adult with stable chronic obstructive pulmonary disease (COPD).

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescription for Stable COPD in an Adult


Patient Name: ________________________________
Date: ________________
DOB: ________________


℞ Primary Maintenance Therapy

Tiotropium (Spiriva Respimat) 2.5 mcg

  • Sig: Inhale 2 puffs (5 mcg total) once daily
  • Disp: 1 inhaler (60 actuations)
  • Refills: 11

OR

Umeclidinium/Vilanterol (Anoro Ellipta) 62.5 mcg/25 mcg

  • Sig: Inhale 1 puff once daily
  • Disp: 1 inhaler (30 doses)
  • Refills: 11

1, 2


℞ Rescue Therapy

Albuterol (ProAir HFA) 90 mcg/actuation

  • Sig: Inhale 2 puffs every 4-6 hours as needed for shortness of breath
  • Disp: 1 inhaler (200 actuations)
  • Refills: 3

1, 3


℞ For High-Risk Patients (≥2 moderate or ≥1 severe exacerbation in past year)

Fluticasone/Salmeterol (Advair Diskus) 250 mcg/50 mcg

  • Sig: Inhale 1 puff twice daily (morning and evening, 12 hours apart)
  • Disp: 1 inhaler (60 doses)
  • Refills: 11

OR

Fluticasone/Umeclidinium/Vilanterol (Trelegy Ellipta) 100 mcg/62.5 mcg/25 mcg

  • Sig: Inhale 1 puff once daily
  • Disp: 1 inhaler (30 doses)
  • Refills: 11

1, 4


℞ For Persistent Exacerbations Despite Triple Therapy (with chronic bronchitis phenotype)

Azithromycin 250 mg tablets

  • Sig: Take 1 tablet (250 mg) three times weekly (e.g., Monday, Wednesday, Friday)
  • Disp: 52 tablets
  • Refills: 3

Note: Obtain baseline ECG (QTc must be <450 ms in men, <470 ms in women), liver function tests, and sputum culture for nontuberculous mycobacteria before initiating. Recheck ECG and LFTs at 1 month, then every 6 months. 1


Prescriber Signature: ________________________________
DEA #: ________________
NPI #: ________________


Instructions:

  • Use spacer device with metered-dose inhalers
  • Rinse mouth after inhaled corticosteroid use
  • Continue smoking cessation efforts
  • Pulmonary rehabilitation referral recommended

1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Guidelines for Managing Chronic Respiratory Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the complete management plan for a patient with Chronic Obstructive Pulmonary Disease (COPD)?
At age 73 with advanced chronic obstructive pulmonary disease and lung function about 30% of predicted, would I benefit from a palliative‑care approach?
Is a dosage of Acebrophylline (Ambroxol derivative and a bronchodilator) 300mg in 24 hours effective for managing Chronic Obstructive Pulmonary Disease (COPD) or asthma?
What are the management options for Chronic Obstructive Pulmonary Disease (COPD)?
Is there a role for Dimethyl Sulfoxide (DMSO) in the management of Chronic Obstructive Pulmonary Disease (COPD)?
What is the recommended management for a patient with chronic obstructive pulmonary disease?
What is the optimal pharmacologic regimen for a stable adult (≥18 years) with chronic obstructive pulmonary disease and for a child (6–12 years) with presumed COPD‑like chronic bronchial disease?
What is the appropriate management for a 4‑year‑old who had a febrile seizure, completed a 5‑day course of oseltamivir (Tamiflu), and now presents with recurrent high fever (105 °F) but is not toxic‑appearing?
Is albumin infusion used to correct hyponatremia?
What should be added next for a COPD patient on once‑daily fluticasone furoate/vilanterol 200/25 µg (Ellipta) and rescue salbutamol?
What is the comprehensive initial assessment and management protocol for a pediatric emergency, covering airway, breathing, circulation, disability, exposure, and weight‑based treatments?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.